Law360, New York (May 14, 2007, 12:00 AM ET) -- Less than a year after Schering-Plough Corp. agreed to pay $435 million to settle Medicaid fraud and improper marketing charges, the drug maker is facing a new class action alleging it engaged in an illegal kickback scheme to market a slew of its prescription medications, causing consumers to overpay “hundreds of millions, if not billions, of dollars.”
The class action lawsuit, filed Thursday by lead plaintiff Angela F. Montgomery in the U.S. District Court for the District of Massachusetts, seeks to recover drug payments made from...
Schering Faces Class Action Over Alleged Kickbacks
To view the full article, take a free trial now.
